Hi all,
I'm sure you have already talked about how to treat biological replicates in RNA-Seq differential expression but I can't find information about how to incorporate RIN values into the DE analysis.
I have iPSCs where some genes have been duplicated (Group - DUP), deleted (Group- DEL) and I have the control group - CTL. The iPSCs are coming from 9 different subjects (3 in each Del, DUP and CTL groups). Each subject has 2 clones (clone X and clone Y) taken for the RNAseq, and each clone was grown in parallel (in 2 different wells) to create relicas (a, b in last column) . Here is my study design:
Sample | RIN | Group | Patient | Clone | Replicate |
101_c1a | 8.6 | CTL | Subjet1 | Clone1 | a |
101_c1b | 9 | CTL | Subjet1 | Clone1 | b |
101_c3a | 9.5 | CTL | Subjet1 | Clone2 | a |
101_c3b | 9.7 | CTL | Subjet1 | Clone2 | b |
11_c1a | 6 | CTL | Subjet2 | Clone3 | a |
11_c1b | 8 | CTL | Subjet2 | Clone3 | b |
11_c6a | 7.7 | CTL | Subjet2 | Clone4 | a |
11_c6b | 8 | CTL | Subjet2 | Clone4 | b |
61_c3a | 8.7 | CTL | Subject3 | Clone5 | a |
61_c3b | 8.9 | CTL | Subject3 | Clone5 | b |
61_c5a | 9.8 | CTL | Subject3 | Clone6 | a |
61_c5b | 9.7 | CTL | Subject3 | Clone6 | b |
16A_c11a | 7.5 | DEL | Subject4 | Clone7 | a |
16A_c11b | 7.1 | DEL | Subject4 | Clone7 | b |
16A_c12a | 8.9 | DEL | Subject4 | Clone8 | a |
16A_c12b | 9.2 | DEL | Subject4 | Clone8 | b |
16B_c10a | 9.4 | DEL | Subject5 | Clone9 | a |
16B_c10b | 9.4 | DEL | Subject5 | Clone9 | b |
16B_c4a | 10 | DEL | Subject5 | Clone10 | a |
16B_c4b | 9.4 | DEL | Subject5 | Clone10 | b |
16C_c2a | 6.7 | DEL | Subject6 | Clone11 | a |
16C_c2b | 7.2 | DEL | Subject6 | Clone11 | b |
16C_c4a | 6 | DEL | Subject6 | Clone12 | a |
16C_c4b | 5.5 | DEL | Subject6 | Clone12 | b |
16X_c1a | 5 | DUP | Subject7 | Clone13 | a |
16X_c1b | 7.3 | DUP | Subject7 | Clone13 | b |
16X_c3a | 5.9 | DUP | Subject7 | Clone14 | a |
16X_c3b | 6 | DUP | Subject7 | Clone14 | b |
16Y_c2a | 5.9 | DUP | Subject8 | Clone15 | a |
16Y_c2b | 6.2 | DUP | Subject8 | Clone15 | b |
16Y_c4a | 5.7 | DUP | Subject8 | Clone16 | a |
16Y_c4b | 5.1 | DUP | Subject8 | Clone16 | b |
16Z_c1a | 5.7 | DUP | Subject9 | Clone17 | a |
16Z_c1b | 7.7 | DUP | Subject9 | Clone17 | b |
16Z_c8a | 5.7 | DUP | Subject9 | Clone18 | a |
16Z_c8b | 5.5 | DUP | Subject9 | Clone18 | b |
I'm interested on the differential gene expression at the Group level (controlvsdup, control vs del and dup vs del). But, should I consider all samples from the same group as biological replicates? The design matrix should be like :
1. ddseq <- DESeqDataSetFromMatrix(countData = counts, colData = metadata, design = ~ Group )
Or should I consider possible differences between patients and clones?
2. ddseq <- DESeqDataSetFromMatrix(countData = counts, colData = metadata, design = ~ Group + Patient)
3. ddseq <- DESeqDataSetFromMatrix(countData = counts, colData = metadata, design = ~ Group + Patient+Clone
And how would you incorporate the RIN values into design matrix?
ddseq <- DESeqDataSetFromMatrix(countData = counts, colData = metadata, design = ~ Group + RIN ) ?
Thanks a lot for your help. Any hint will be more than appreciated : )
Best,
Patricia